Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 1,247 | 1,149 | 1,373 | 859 | 1,590 |
| Gross Profit | 1,247 | 1,149 | 1,373 | 859 | 1,590 |
| Operating Expenses | 6,790 | 7,450 | 6,868 | 5,426 | 5,600 |
| Operating Income | -5,543 | -6,301 | -5,495 | -4,567 | -4,010 |
| Other Income | 60 | 63 | 65 | 20 | 10 |
| Pre-tax Income | -5,483 | -6,238 | -5,430 | -4,547 | -4,000 |
| Net Income Continuous | -5,483 | -6,238 | -5,430 | -4,547 | -4,000 |
| Net Income | $-5,483 | $-6,238 | $-5,430 | $-4,547 | $-4,000 |
| EPS Basic Total Ops | 145.25 | -11.75 | -11.50 | -177.50 | -162.25 |
| EPS Basic Continuous Ops | 145.25 | -11.70 | -11.53 | -177.42 | -163.03 |
| EPS Diluted Total Ops | 145.25 | -11.75 | -11.50 | -177.50 | -162.25 |
| EPS Diluted Continuous Ops | 145.25 | -11.70 | -11.53 | -177.42 | -163.03 |
| EBITDA(a) | $-5,457 | $-6,230 | $-5,450 | $-4,536 | $-3,994 |